文献速递免疫规划

埃及婴儿期全程接种疫苗儿童对乙肝疫苗加强剂量的早期和长期回忆应答

Early and long term anamnestic response to HBV booster dose among fully vaccinated Egyptian children during infancy.
PubMed 文献 · Vaccine · 2018-03-09

埃及一项基于社区的全国项目纳入3600名婴儿期全程接种乙肝疫苗的9月龄至16岁儿童,其中1535名(42.8%)抗-HBs非血清保护(<10 IU/L)且HBsAg或抗-HBc阴性,对其中1121名给予10 μg单价Euvax乙肝疫苗加强剂量。早期回忆应答在967/1070名儿童(90.3%)中发生,一年后先前有早期应答者中15%缺乏长期回忆应答。结论认为乙肝疫苗免疫记忆比抗-HBs存在更持久,即使抗-HBs衰减或检测不到,疫苗接种规划仍提供有效长期保护,尤其健康儿童无需加强剂量。

要点

  • 1535/3600名儿童(42.8%)抗-HBs<10 IU/L且HBsAg或抗-HBc阴性。
  • 加强后早期回忆应答967/1070名(90.3%),抗-HBs可检测者90% vs 不可检测者85%,P<0.001。
  • 一年后先前有早期应答者中15%缺乏长期回忆应答。

核心结论

  • 乙肝疫苗免疫记忆比抗-HBs存在更持久,乙肝疫苗接种规划提供有效长期保护,即使儿童抗-HBs浓度衰减或检测不到,尤其健康儿童无需加强剂量。

研究设计与样本

  • national community based project纳入3600名9月龄至16岁婴儿期全程接种儿童,来自代表埃及的6个省。
  • 1535名抗-HBs非血清保护(<10 IU/L)且HBsAg或抗-HBc阴性儿童中,1121名接受10 μg单价Euvax乙肝疫苗挑战剂量。
  • 定量检测抗-HBs以评估早期(2-4周)和长期(一年)回忆应答。

主要发现

  • 早期回忆应答在967/1070名儿童中发生(90.3%)。
  • 抗-HBs可检测(1-9 IU/L)儿童早期回忆应答90% vs 抗-HBs不可检测(<1 IU/L)儿童85%,P<0.001。
  • 多因素logistic分析显示抗-HBs不可检测、农村居住和15-16岁是缺乏早期回忆应答(<10 IU/L)的最显著预测危险因素,AOR分别为2.7、2.7和4.7。
  • 一年后,先前显示早期应答的儿童中15%缺乏长期回忆应答。
  • 早期回忆应答差和加强前抗-HBs不可检测是缺乏长期回忆应答的显著预测危险因素,AOR分别为18.7和2.7。

临床怎么用

  • 原文结论认为乙肝疫苗接种规划提供有效长期保护,尤其健康儿童无需加强剂量。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate early and long term anamnestic response to a booster dose of HBV vaccine among non-seroprotected children. SUBJECTS AND METHOD: A national community based project was carried out on 3600 children aged 9 months to 16 years, fully vaccinated during infancy. They were recruited from 6 governorates representing Egypt. It revealed that 1535 children (42.8%) had non sero-protective anti-HBs (<10 IU/L) and were HBsAg or anti-HBc negative. A challenging dose of 10 μg of mono-valent Euvax HBV vaccine was given to 1121/1535 children. Quantitative assessment of anti-HBs was performed to detect early (2-4 weeks) and long term (one year) anamnestic responses. RESULTS: Early anamnestic response developed among 967/1070 children (90.3%).Children having detectable anti-HBs (1-9 IU/L) significantly developed early anamnestic response (90%) compared to 85% with undetectable anti-HBs (<1 IU/L), P < 0.001. Multiple logistic analysis revealed that undetectable anti-HBs, living in rural residence and children aged 15-16 years were the most significant predicting risk factors for the absence of early anamnestic response (<10 IU/L), with AOR 2.7, 2.7 & 4.7 respectively. After one year, long term anamnestic response was absent among 15% of children who previously showed early response. Poor early anamnestic response and undetectable pre-booster anti-HBs were the significant predicting risk factors for absent long term anamnestic response, with AOR 18.7 & 2.7 respectively. CONCLUSION: Immunological memory for HBV vaccine outlasts the presence of anti- HBs and HBV vaccination program provides effective long term protection even in children showing waning or undetectable concentrations of anti-HBs. This signifies no need for a booster dose especially to healthy children.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Salama II, Sami SM, Said ZN, et al. Early and long term anamnestic response to HBV booster dose among fully vaccinated Egyptian children during infancy. Vaccine. 2018. PMID: 29530634. doi:10.1016/j.vaccine.2018.02.103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。